A meta-analysis including dose-response relationship between night shift work and the risk of colorectal cancer

Oncotarget

Volumn 6, Issue 28, 2015, Pages 25046-25060

  Wang, Xiao ^a   Ji, Alin ^a   Zhu, Yi ^a   Liang, Zhen ^a   Wu, Jian ^a   Li, Shiqi ^a   Meng, Shuai ^a   Zheng, Xiangyi ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Colorectal cancer; Epidemiology; Meta analysis; Night shift work; Risk factor

Indexed keywords

ARTICLE; CANCER RISK; COLORECTAL CANCER; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; LONG TERM EXPOSURE; NIGHT WORK; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; CIRCADIAN RHYTHM; COLORECTAL NEOPLASMS; FEMALE; MALE; META ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PERSONNEL MANAGEMENT; RISK FACTOR; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; TIME FACTOR;

CIRCADIAN RHYTHM; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; ODDS RATIO; PERSONNEL STAFFING AND SCHEDULING; RISK ASSESSMENT; RISK FACTORS; SLEEP; SLEEP DISORDERS, CIRCADIAN RHYTHM; TIME FACTORS;

EID: 84944472731     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4502     Document Type: Article

References (44)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87-108.
2. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005; 6:871-876.
3. Wang X, Lin YW, Wang S, Wu J, Mao QQ, Zheng XY, Xie LP. A meta-analysis of tea consumption and the risk of bladder cancer. Urol Int. 2013; 90:10-16.
4. Wang X, Lin YW, Wu J, Zhu Y, Xu XL, Xu X, Liang Z, Hu ZH, Li SQ, Zheng XY, Xie LP. Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk. World J Surg Oncol. 2014; 12:304.
5. Cheng J, Chen Y, Wang X, Wang J, Yan Z, Gong G, Li G, Li C. Meta-analysis of prospective cohort studies of cigarette smoking and the incidence of colon and rectal cancers. Eur J Cancer Prev. 2015; 24:6-15.
6. Wang XS, Armstrong ME, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011; 61:78-89.
7. DeChello LM, Sheehan TJ. Spatial analysis of colorectal cancer incidence and proportion of late-stage in Massachusetts residents: 1995-1998. Int J Health Geogr. 2007; 6:20.
8. Siu LL, Shapiro JD, Jonker DJ, Karapetis CS, Zalcberg JR, Simes J, Couture F, Moore MJ, Price TJ, Siddiqui J, Nott LM, Charpentier D, Liauw W, Sawyer MB, Jefford M, Magoski NM, et al. Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG, CO.20 Trial. J Clin Oncol. 2013; 31:2477-2484.
9. Wang F, Yeung KL, Chan WC, Kwok CC, Leung SL, Wu C, Chan EY, Yu IT, Yang XR, Tse LA. A meta-analysis on dose-response relationship between night shift work and the risk of breast cancer. Ann Oncol. 2013; 24:2724-2732.
10. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Altieri A, Benbrahim-Tallaa L, Cogliano V. Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol. 2007; 8:1065-1066.
11. Papantoniou K, Kogevinas M, Martin Sanchez V, Moreno V, Pollan M, Moleon JJ, Ardanaz E, J MA, Peiro R, Tardon A, Alguazil J, Navarro C, Gomez-Acebo I, Castano-Vimyals G. 0058 Colorectal cancer risk and shift work in a population-based case-control study in Spain (MCC-Spain). Occup Environ Med. 2014; 71:A5-6.
12. Tsai RJ, Luckhaupt SE, Sweeney MH, Calvert GM. Shift work and cancer screening: do females who work alternative shifts undergo recommended cancer screening? Am J Ind Med. 2014; 57:265-275.
13. Parent ME, El-Zein M, Rousseau MC, Pintos J, Siemiatycki J. Night work and the risk of cancer among men. Am J Epidemiol. 2012; 176:751-759.
14. Schwartzbaum J, Ahlbom A, Feychting M. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health. 2007; 33:336-343.
15. Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Fuchs CS, Colditz GA. Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst. 2003; 95:825-828.
16. Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T. Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control. 1996; 7:197-204.
17. Wang X, Xu X, Wu J, Zhu Y, Lin Y, Zheng X, Xie L. Systematic review and meta-analysis of the effect of alcohol intake on the risk of urolithiasis including dose-response relationship. Urol Int. 2015; 94:194-204.
18. Innominato PF, Roche VP, Palesh OG, Ulusakarya A, Spiegel D, Levi FA. The circadian timing system in clinical oncology. Ann Med. 2014; 46:191-207.
19. Schibler U, Sassone-Corsi P. A web of circadian pacemakers. Cell. 2002; 111:919-922.
20. Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature. 2002; 418:935-941.
21. Zhang J, Kaasik K, Blackburn MR, Lee CC. Constant darkness is a circadian metabolic signal in mammals. Nature. 2006; 439:340-343.
22. Ruby NF, Dark J, Burns DE, Heller HC, Zucker I. The suprachiasmatic nucleus is essential for circadian body temperature rhythms in hibernating ground squirrels. J Neurosci. 2002; 22:357-364.
23. Enoki R, Kuroda S, Ono D, Hasan MT, Ueda T, Honma S, Honma K. Topological specificity and hierarchical network of the circadian calcium rhythm in the suprachiasmatic nucleus. Proc Natl Acad Sci U S A. 2012; 109:21498-21503.
24. Kruijver FP, Swaab DF. Sex hormone receptors are present in the human suprachiasmatic nucleus. Neuroendocrinology. 2002; 75:296-305.
25. Brown SA, Zumbrunn G, Fleury-Olela F, Preitner N, Schibler U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr Biol. 2002; 12:1574-1583.
26. Lin C, Tang X, Zhu Z, Liao X, Zhao R, Fu W, Chen B, Jiang J, Qian R, Guo D. The rhythmic expression of clock genes attenuated in human plaque-derived vascular smooth muscle cells. Lipids Health Dis. 2014; 13:14.
27. Costa G, Haus E, Stevens R. Shift work and cancerconsiderations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health. 2010; 36:163-179.
28. Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev. 2009; 13:257-264.
29. Wei JY, Li WM, Zhou LL, Lu QN, He W. Melatonin induces apoptosis of colorectal cancer cells through HDAC4 nuclear import mediated by CaMKII inactivation. J Pineal Res. 2015; 58:429-438.
30. Rich T, Innominato PF, Boerner J, Mormont MC, Iacobelli S, Baron B, Jasmin C, Levi F. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res. 2005; 11:1757-1764.
31. Wang S, Wang X, Wu J, Lin Y, Chen H, Zheng X, Zhou C, Xie L. Association of vitamin D receptor gene polymorphism and calcium urolithiasis in the Chinese Han population. Urol Res. 2012; 40:277-284.
32. Chandler PD, Buring JE, Manson JE, Giovannucci EL, Moorthy MV, Zhang S, Lee IM, Lin JH. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women. Cancer Prev Res (Phila). 2015.
33. Ward M, Berry DJ, Power C, Hypponen E. Working patterns and vitamin D status in mid-life: a cross-sectional study of the 1958 British birth cohort. Occup Environ Med. 2011; 68:902-907.
34. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6:e1000097.
35. Xu X, Zhu Y, Zheng X, Xie L. Does beer, wine or liquor consumption correlate with the risk of renal cell carcinoma? A dose-response meta-analysis of prospective cohort studies. Oncotarget. 2015.
36. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7:177-188.
37. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute. 1959; 22:719-748.
38. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003; 327:557-560.
39. Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H, Moons KG. More than numbers: the power of graphs in meta-analysis. American journal of epidemiology. 2009; 169:249-255.
40. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992; 135:1301-1309.
41. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. American journal of epidemiology. 2012; 175:66-73.
42. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-634.
43. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088-1101.
44. Duval S, Tweedie R. Trim and fill: A simple funnel-plotbased method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000; 56:455-463.